Showing posts with label fluorescence. Show all posts
Showing posts with label fluorescence. Show all posts

24 January 2014

New Process Developed To Image How The Brain Forms Memories


Researchers at Albert Einstein College of Medicine of Yeshiva University have imaged the brain while forming memories on the molecular level. This was achieved by tagging fluorescent beta-actin mRNA molecules using a mouse model.

The tagged molecules were observed by the scientists in real time while brain cells were forming memories. See embedded video.

They note that the stimulated individual hippocampal neurons caused a rapid transcription of the beta-actin gene within 10 to 15 minutes. The hippocampus is the region of the brain where where memories are made and stored. These beta-actin mRNA molecules continuously assemble and disassemble into large and small particles, respectively. These mRNA particles were seen traveling to their destinations in dendrites where beta-actin protein would be synthesized.

The neurons connect to each other through spines of dendrites where long-lasting synaptic connections form between neurons in contact with each other. The Beta-actin protein appears to strengthen these synaptic connections by altering the shape of dendritic spines.

19 February 2013

Using 5 ALA Fluorescence in Surgical Treatment of Glioblastoma Multiforme


The University of California San Francisco describes the use of 5-aminolevulinic acid (5-ALA) fluorescence to aid in visualizing tumor cells and differentiating them from other brain tissue during the surgical treatment of Glioblastoma Multiforme.

5-Aminolevulinic Acid (5-ALA) makes brain tumor cells glow hot pink when illuminated with a special blue light incorporated into an operating microscope during surgery. The light helps to identify and remove tumor cells in a process called Fluorescent Guided Resection (FGR).

Glioblastoma Multiforme (GBM) is the most common and also the deadliest of brain cancers around. This form of cancer is very aggressive and a patient diagnosed with GBM has one to two years to live.

The cancerous tumor, called a glioma, starts in the brain or the spine. These gliomas are graded I to IV depending on how advanced the disease is. A Grade I GBM is the least advanced and offers the best prognosis. A Grade IV GBM is considered the most advanced and the hardest to treat.

Gliomas are groups of tumors that arise from the glia. Glias are non-neuronal cells that maintain homeostasis. They form myelin (a protective layer of cells), and provide support and protection for neurons in the brain within the central nervous system (CNS).